SMC approves prostate cancer drug
A cancer drug which reportedly helped keep the Lockerbie bomber alive for an extra two-and-a-half years is to be made available on the NHS in Scotland.
Continue reading this article – simply subscribe below
Subscribe now for instant access to hsj.co.uk and our mobile site. Choose the package that suits you and get the weekly magazine, iPad app or both.
If you are a Health Service Journal subscriber please sign in with your email address and click submit: